Literature DB >> 17003947

[Bibrocathol eye ointment is efficacious in blepharitis. Results from a randomized, double-blind, controlled clinical trial].

W Behrens-Baumann1, C Niederdellmann, A Jehkul, R Kohnen.   

Abstract

Bibrocathol (Noviform) 5% ointment is a frequently used therapy for blepharitis. The study included 197 patients who were randomized to be treated over 2 weeks with bibrocathol or an ointment vehicle, respectively. Slit lamp examinations were performed on day 1 (baseline) and day 14 (end of study) to assess lid edema, lid erythema, debris, and pouting of Meibomian glands; patients rated their subjective complaints. Bibrocathol was superior to the control treatment in improving the sum score of the 5 scales (by 7.0 vs 4.7 points, p<0.001), especially in patients with primarily severe symptoms (by 8.3 vs 4.8, p<0.0001). Antiseptic therapy with bibrocathol eye ointment 3 times daily over 2 weeks was found to be efficacious in the treatment of acute forms of blepharitis which do not require antibiotic therapy. Bibrocathol treatment is well tolerated and safe.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003947     DOI: 10.1007/s00347-006-1426-4

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  7 in total

Review 1.  Infectious disease: changing antibiotic susceptibility.

Authors:  Regis P Kowalski; Lisa M Karenchak; Eric G Romanowski
Journal:  Ophthalmol Clin North Am       Date:  2003-03

Review 2.  Microbial colonization of the eye as target for antiseptics.

Authors:  A Kramer; W Behrens-Baumann
Journal:  Dev Ophthalmol       Date:  2002

Review 3.  [Anti-infective drug therapy in ophthalmology -- Part 1: bacterial infections].

Authors:  W Behrens-Baumann
Journal:  Klin Monbl Augenheilkd       Date:  2004-07       Impact factor: 0.700

Review 4.  Changing concepts in the diagnosis and management of blepharitis.

Authors:  J P McCulley; W E Shine
Journal:  Cornea       Date:  2000-09       Impact factor: 2.651

Review 5.  [Blepharitis].

Authors:  T Kaercher; H Brewitt
Journal:  Ophthalmologe       Date:  2004-11       Impact factor: 1.059

6.  Antiseptics versus antibiotics in the treatment of the experimental conjunctivitis caused by Staphylococcus aureus.

Authors:  W Behrens-Baumann; T Begall
Journal:  Ger J Ophthalmol       Date:  1993-11

7.  Comparative bacteriology of chronic blepharitis.

Authors:  J M Dougherty; J P McCulley
Journal:  Br J Ophthalmol       Date:  1984-08       Impact factor: 4.638

  7 in total
  3 in total

Review 1.  Interventions for chronic blepharitis.

Authors:  Kristina Lindsley; Sueko Matsumura; Elham Hatef; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  Successful treatment of blepharitis with bibrocathol (Posiformin® 2 %).

Authors:  Pavel A Bezdetko; Nikolai Sergienko; Yuriy Dyomin; Andrei Korol; Nik Nikitin; Matthias Merzbacher; Dorothea Groß; Ralf Kohnen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-25       Impact factor: 3.117

3.  Randomized double-blind trial of wipes containing terpinen-4-ol and hyaluronate versus baby shampoo in seborrheic blepharitis patients.

Authors:  Ceyhun Arici; Burak Mergen; Ayse Yildiz-Tas; Hrisi Bahar-Tokman; Edip Tokuc; Yesim Ozturk-Bakar; Zekayi Kutlubay; Afsun Sahin
Journal:  Eye (Lond)       Date:  2021-06-28       Impact factor: 3.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.